Aerpio: AERPIO ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of ARPO and Encourages Investors to Contact the Firm

NEW YORK, May 27, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO) breached their fiduciary duties or violated the federal securities laws in connection with the company's merger with Aadi Bioscience, Inc. Click here to learn more and participate in the action. On May 17, 2021, Aerpio announced that it had signed an agreement to be acquired by Aadi in an all-stock merger. Pursuant to the merger agreement, at the close of the merger Aerpio stockholders will own approximately 33.2% ...Full story available on Benzinga.com